Become a member and receive career-enhancing benefits
Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.
Become a member and receive career-enhancing benefits
Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.
President Biden has nominated Monica Bertagnolli, MD, FACS, a world-renowned oncologic surgeon and cancer researcher, to lead the US National Institutes of Health (NIH).
“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” President Biden said in a statement. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.”
If approved by the Senate, she would be the first board-certified surgeon to serve in this role, as well as the second woman.
Dr. Bertagnolli currently is the director of the National Cancer Institute (NCI)—the first woman to serve in that role—to which she was appointed in 2022. Previously, Dr. Bertagnolli served as the Richard E. Wilson Professor of Surgery in surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute, all in Boston, Massachusetts.
She has decades of experience in clinical research and executive leadership in oncology and cancer policy, including her role as chair of the Alliance for Clinical Trials in Oncology, a clinical trials cooperative group funded through NCI’s National Clinical Trials Network.
An ACS Fellow since 1996, Dr. Bertagnolli delivered the Commission on Cancer Oncology Lecture at Clinical Congress 2011.
Wood Receives NCCN Rodger Winn Award
ACS Regent Douglas E. Wood, MD, FACS, FRCSEd, was awarded the prestigious Rodger Winn Award from the National Comprehensive Cancer Network (NCCN) for his work on the NCCN Clinical Practice Guidelines in Oncology and his leadership in the development of the NCCN Lung Cancer Screening Guidelines. The Rodger Winn Award was named in memory of the first leader of the NCCN Guidelines Program.
Dr. Wood founded and has chaired the NCCN Lung Cancer Screening Guideline Panel since its inception in 2009. As chair, he has been unwavering in his commitment to develop lung cancer screening recommendations and has served as a public representative in many forums to champion the guidelines.
“I am truly honored and humbled by this recognition,” Dr. Wood said. “I am so appreciative of the incredible NCCN staff that I am privileged to work with, and the other volunteers that I learn from year after year. The work we do together at NCCN is so important to minimizing unjustified practice variation, supporting clinicians to keep up to date with rapidly changing practice, educating and empowering patients about their treatment options, and improving cancer care nationally and worldwide.”
The Henry N. Harkins Professor and chair of the Department of Surgery at the University of Washington in Seattle, Dr. Wood is the first cardiothoracic surgeon to receive the Rodger Winn Award.
Preventza Will Lead Cardiothoracic Surgery at UVA
Cardiothoracic surgeon Ourania Preventza, MD, MBA, FACS, has been appointed the new chief of the Division of Cardiothoracic Surgery and co-director of the Heart and Vascular Service Line at the University of Virginia (UVA) Health. She will assume the role on June 19.
Internationally known for her work in complex cardiac and aortic surgery, Dr. Preventza currently is a professor of surgery and assistant program director of the thoracic surgery integrated residency and independent fellowship at Baylor College of Medicine in Waco, Texas. She serves as president of the International Society of Endovascular Specialists and has been a leader in several other organizations, including The Society of Thoracic Surgeons and the American Association for Thoracic Surgery.
Haws Is New President of The Aesthetic Society
Melinda J. Haws, MD, FACS, has been elected president of The Aesthetic Society, the world’s leading organization devoted to aesthetic plastic surgery and cosmetic medicine of the face and body. A plastic and reconstructive surgeon at the Plastic Surgery Center of Nashville in Tennessee, Dr. Haws aims to focus on advancing the Aesthetic Society’s technology strategy, expanding membership, and positioning the organization for the future. She is board-certified by the American Board of Plastic Surgery.
Have you or an ACS member you know achieved a notable career highlight recently? If so, send potential contributions to Jennifer Bagley, MA, Bulletin Editor-in-Chief, at jbagley@facs.org. Submissions will be printed based on content type and available space.
